Oral methotrexate therapy for chronic rheumatoid arthritis ulcerations.
Eight patients with long-standing rheumatoid arthritis and cutaneous vasculitis ulcerations resistant to conventional therapy were treated successfully with a low-dose intermittent regimen of oral methotrexate. Objective clinical response was prompt and complete resolution was observed at about 12 weeks of therapy. The drug was well tolerated. Mild gastrointestinal side effects were the most common untoward reaction. We conclude that methotrexate therapy is an effective agent for some of the extraarticular manifestations of rheumatoid arthritis including vasculitis, and further clinical evaluation should be a consideration.
D000368:Aged; D001172:Arthritis, Rheumatoid / Q000150:complications*; D001424:Bacterial Infections / Q000209:etiology; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects; D008297:Male; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012737:Sex Factors; D012883:Skin Ulcer / Q000188:drug therapy* / Q000209:etiology; D014657:Vasculitis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology / Q000473:pathology
D011241:Prednisone; D008727:Methotrexate